Dasatinib: A Review in Pediatric Chronic Myeloid Leukemia

Overview of attention for article published in Pediatric Drugs, November 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 2 X users

googleplus: 1 Google+ user

Citations

dimensions_citation: 19 Dimensions

Readers on

mendeley: 38 Mendeley

Summary X Google+ Dimensions citations

So far, Dimensions has found 19 publications that cite this research output.

19

The most recent citing publications are shown below. View all 19 publications that cite this research output on Dimensions.

Dose optimization strategy of the tyrosine kinase inhibitors imatinib, dasatinib, and nilotinib for chronic myeloid leukemia: From clinical trials to real-life settings

Article in Frontiers in Oncology (April 2023)

Non-hippo kinases: indispensable roles in YAP/TAZ signaling and implications in cancer therapy

Article in Molecular Biology Reports (March 2023)

Senolytic drugs, dasatinib and quercetin, attenuate adipose tissue inflammation, and ameliorate metabolic function in old age

Article in Aging Cell (January 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.